Our laboratory has developed a mouse model to study mechanisms that constrain CD4+ T cell-mediated immunity to melanoma antigens that are also self antigens [22], using the tyrosinase-related protein (TRP) 1-specific TCR transgenic mouse model generated previously [19]. Here, CD4 is linked to melanoma.